Dr. Marc Gomes is an interventional cardiologist with extensive experience in the diagnosis and treatment of a wide range of cardiovascular conditions. Dr. Gomes graduated Cum Laude. In his practice, he focuses on the patient as a whole, not only addressing the immediate complaint or diagnosis, but also considering underlying risk factors, lifestyle, and individual circumstances. He strongly values shared decision-making and takes the time to listen carefully and explain clearly what is going on and what the available treatment options are. Accessible care, clear communication, and a personal approach are central to his practice. In addition to treatment, Dr. Gomes places strong emphasis on prevention and risk stratification. By identifying and addressing cardiovascular risks at an early stage, complications can often be prevented. His goal is not only to treat current symptoms, but to improve long-term health and quality of life.
Specialty / areas of interest
Interventional cardiology
Cardiovascular risk stratification and prevention
Acute cardiology and chest pain pathways
Cardiac diagnostics and imaging
Healthcare innovation and organization
Languages
Dutch, English
Work Experience
2012 – present: Interventional Cardiologist, Canisius Wilhelmina Hospital, Nijmegen
2011 – 2012: Fellow Interventional Cardiology, Catharina Hospital, Eindhoven
Leadership Roles
Chairman, Medical Staff Board, CWZ (2018–2023)
Vice Chairman, Medical Staff Board, CWZ (2015–2018)
Chairman, Santeon Medical Staff Collective (2020–2023)
Medical Manager, Cardiology Partnership
Chairman, Medical Specialist Company (MSB) Cardiology (2015–2026)
Chairman, Cardiology Partnership (2013–2015)
Acting Medical Director, Clinical Research Center Nijmegen, Radboud University Medical Center (2007)
Education
2012: Interventional Cardiology Training
2011: Board Certification in Cardiology
2011: PhD, Radboud University Nijmegen
2009: Internal and External Management for Medical Professionals
2003: Medical Degree (cum laude), AMC Amsterdam
2000: Doctoral Degree in Medicine (cum laude), AMC Amsterdam
1997: Preclinical Medicine (cum laude), AMC Amsterdam
1996: Preclinical Medicine, KU Leuven
PhD Thesis
Inhibition of sympathetic activity and modulation of insulin resistance in cardiovascular disease, Radboud University Nijmegen, 2011
Extracurricular / Academic Activities
Principal and Sub-Investigator in multiple clinical studies
Active in healthcare innovation and organizational development
Member, Negotiation Team with Health Insurers, CWZ (2013–2025)
Member, Committee “Future Clinical Care”, CWZ (2013–2017)
Member, Recruitment and Selection Committee, CWZ (2012–2024)
Lead, Renal Denervation Program (2012–2016)
Member, Committee “Model Admission Agreement” (2012–2014)
Member, Committee “Practice Costs” (2012–2014)
Research Associate, Maasstad Cardiology Research (MCR), Maasstad Hospital & Sahlgrenska University Hospital, Gothenburg (2011–2012)
Member, Committee “Acute Admissions”, Radboud University Medical Center (2009–2011)
Member, Executive Board, Central Training Committee, Radboud University Medical Center (2009–2011)
Acting Medical Director, Clinical Research Center Nijmegen, Radboud University Medical Center (2007)
Reviewer for international journals including Circulation and Diabetes Care (2006–2010)
Membership
Member Dutch Society of Cardiology (NVVC)
Member European Society of Cardiology (ESC)
Publications
1. Aarts GWA, Camaro C, Adang EMM, Rodwell L, van Hout R, Brok G, Hoare A, de Pooter F, de Wit W, Cramer GE, van Kimmenade RRJ, Ouwendijk E, Rutten MH, Zegers E, van Geuns RM, Gomes MER, Damman P, van Royen N. Pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome by a single troponin: final one-year outcomes of the ARTICA randomised trial. Eur Heart J Qual Care Clin Outcomes. 2024 Aug 8;10(5):411-420
2. Aarts GWA, Camaro C, Rodwell L, Adang EMM, van Hout R, Brok G, Hoare A, de Pooter FPC, de Wit W, Cramer GE, van Kimmenade RRJ, Ouwendijk E, Rutten M, Zegers E, van Geuns RM, Gomes MER, Damman P, van Royen N. Differences in risk and costs between prehospital identified low-risk men and women with chest pain. Open Heart. 2023 Nov 27;10(2):e002390. doi: 10.1136/openhrt-2023-002390.
3. Cyril Camaro, Goaris W. A. Aarts, EddyM.M. Adang, Roger van Hout, Gijs Brok, Anouk Hoare, Laura Rodwell, Frank de Pooter, Walter de Wit, Gilbert E. Cramer, Roland R. J. van Kimmenade, Peter Damman, Eva Ouwendijk, Martijn Rutten, Erwin Zegers, Robert-Jan M. van Geuns, Marc E. R. Gomes, and Niels van Royen on behalf of the ARTICA Investigators. Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial. European Heart Journal (2023) 00, 1–11
4. Elders J, AlHashimi H, Gomes M, Panhuizen I, van Kuijk S, Vernooy K. Subcutaneous ICD implantation under ultrasound-guided serratus anterior plane block: Single-center experience in the Netherlands. Int J Cardiol Heart Vasc. 2022 Jan 5;38:100949. doi: 10.1016/j.ijcha.2021.100949. PMID: 35028411; PMCID: PMC8739453.
5. Aarts GWA, Camaro C, van Geuns RJ, Cramer E, van Kimmenade RRJ, Damman P, van Grunsven PM, Adang E, Giesen P, Rutten M, Ouwendijk O, Gomes MER, van Royen N. Acute rule-out of non-ST-segment elevation acute coronary syndrome in the (pre)hospital setting by HEART score assessment and a single point-of-care troponin: rationale and design of the ARTICA randomised trial. BMJ Open. 2020 Feb 17;10(2):e034403. doi: 10.1136/bmjopen-2019-034403. PMID: 32071186; PMCID: PMC7044902.
6. Noz MP, Bekkering S, Groh L, Nielen TM, Lamfers EJ, Schlitzer A, El Messaoudi S, van Royen N, Huys EH, Preijers FW, Smeets EM, Aarntzen EH, Zhang B, Li Y, Bremmers ME, van der Velden WJ, Dolstra H, Joosten LA, Gomes ME, Netea MG, Riksen NP. Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease. Elife. 2020 Nov 10;9:e60939. Doi 10.7554/eLife.60939. PMID: 33168134; PMCID: PMC7665893.
7. Kiers D, van der Heijden WA, van Ede L, Gerretsen J, de Mast Q, van der Ven AJ, El Messaoudi S, Rongen GA, Gomes M, Kox M, Pickkers P, Riksen NP. A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia. Thromb Haemost. 2017 Aug 30;117(9):1798-1807.
8. Bekkering S, van den Munckhof I, Nielen T, Lamfers E, Dinarello C, Rutten J, de Graaf J, Joosten LA, Netea MG, Gomes ME, Riksen NP. Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. Atherosclerosis. 2016 Nov;254:228-236
9. Sanders MF1, Blankestijn PJ, Voskuil M, Spiering W, Vonken EJ, Rotmans JI, van der Hoeven BL, Daemen J, van den Meiracker AH, Kroon AA, de Haan MW, Das M, Bax M, van der Meer IM, van Overhagen H, van den Born BJ, van Brussel PM, van der Valk PH, Smak Gregoor PJ, Meuwissen M, Gomes ME, Oude Ophuis T, Troe E, Tonino WA, Konings CJ, de Vries PA, van Balen A, Heeg JE, Smit JJ, Elvan A, Steggerda R, Niamut SM, Peels JO, de Swart JB, Wardeh AJ, Groeneveld JH, van der Linden E, Hemmelder MH, Folkeringa R, Stoel MG, Kant GD, Herrman JP, van Wissen S, Deinum J, Westra SW, Aengevaeren WR, Parlevliet KJ, Schramm A, Jessurun GA, Rensing BJ, Winkens MH, Wierema TK, Santegoets E, Lipsic E, Houwerzijl E, Kater M, Allaart CP, Nap A, Bots ML. Safety and long-term effects of renal denervation: Rationale and design of the Dutch registry. Neth J Med. 2016;74:5-15.
10. Tunjungputri RN, van der Ven AJ, Riksen N, Rongen G, Tacke S, van den Berg TN, Fijnheer R, Gomes ME, Dinarello CA, van de Veerdonk FL, Gasem MH, Netea MG, Joosten LA, de Groot PG, de Mast Q. Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses. Thromb Haemost. 2015;113:1035-45
11. Van den Berg TN, El Messaoudi S, Rongen GA, van den Broek PH, Bilos A, Donders AR, Gomes ME, Riksen NP. Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo. PLoS One. 2015;28;10(10):e0137560. doi: 10.1371
12. Elvin Kedhi, Marc E Gomes, Bo Lagerqvist, J. Gustav Smith, Elmir Omerovic, Stefan James, Jan Harnek, Göran K. Olivecrona. The Clinical Impact of the Second Generation Everolimus-eluting stent Compared to the First Generation Drug-Eluting Stents in Diabetes Mellitus Patients: Insights from a nation-wide coronary intervention register. JACC Cardiovasc Interv. 2012;5:1141-9
13. Matthijs Kox, Monique Stoffels, Sanne P. Smeekens, Nens van Alfen, Marc Gomes, Thijs M.H. Eijsvogels, Maria T.E. Hopman, Johannes G. van der Hoeven, Mihai G. Netea, and Peter Pickkers. The influence of concentration/meditation on autonomic nervous system activity and the innate immune response: a case study. Psychosomatic Medicine, 2012;74:489-94
14. Kedhi E, Gomes M, Joesoef KS, Wassing J, Goedhart D, McFadden E, Smits PC. Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial. EuroIntervention. 2012;7:1376-85
15. M.E.R. Gomes, S. El Messaoudi, J.W.M. Lenders, L. Bellersen, F.W.A. Verheugt, P. Smits, C.J. Tack. High dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failure. J Clin Pharm Ther. 2011;36:546-52
16. M.E.R. Gomes, C.J. Tack, F.W.A. Verheugt, P. Smits, J.W.M. Lenders. Sympathoinhibition by atorvastatin in hypertensive patients. Circulation Journal, 2010;74:2622-6
17. M.E.R. Gomes, A. Mulder, L. Bellersen, F.W.A. Verheugt, P. Smits, C.J. Tack. Alpha-receptor blockade improves muscle perfusion and glucose uptake in heart failure. Eur J Heart Failure 2010;12:1061-6
18. Marc E Gomes, Paul Smits, Freek W Verheugt, Cees J Tack. Effect of PCI on inflammatory markers, adiponectin and insulin resistance. Eurointervention 2010;5:838-40
19. ME Gomes, JWM Lenders, L Bellersen, FWA Verheugt, P Smits, CJ Tack. Sympatho-inhibitory effect of statins in chronic heart failure. Clinical Autonomic Research 2010;20:73-8
20. Marc E Gomes, Wim R Aengevaeren, Jacques W Lenders, Freek W Verheugt, Paul Smits, Cees J Tack. Improving Myocardial Perfusion by Percutaneous Coronary Intervention Reduces Central Sympathetic Activity in Stable Angina. Clinical Cardiology 2010;33:E16-21
21. M.E.R. Gomes. Uitleg over de betekenis van een normale testuitslag verbetert geruststelling patiënt. Ned Tijdschr Geneesk 2007;151(18): 1042
22. M.E.R. Gomes, J. Deinum, H. Timmers, J.W.M. Lenders. Occam’s razor in a patient with anemia and orthostatic hypotension. Lancet 2003;362:1282
23. M.E.R. Gomes, J.C. de Graaff, J.A. van Gurp, I. Zwiers, D.A. Legemate. Interobserver variation in duplex scanning of infrainguinal arterial bypass grafts. Eur J Vasc Endovasc Surg 2003;25:224-228
